Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Change in Intangibles (2022)

ImmunityBio (IBRX) has disclosed Change in Intangibles for 2 consecutive years, with $21.2 million as the latest value for Q1 2022.

  • Quarterly Change in Intangibles changed N/A to $21.2 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $21.2 million through Dec 2022, changed N/A year-over-year, with the annual reading at $21.2 million for FY2022, N/A changed from the prior year.
  • Change in Intangibles for Q1 2022 was $21.2 million at ImmunityBio, up from -$342000.0 in the prior quarter.
  • The five-year high for Change in Intangibles was $21.2 million in Q1 2022, with the low at $21.2 million in Q1 2022.